Dr. Greten on Promising Immunotherapy Agents in HCC

Tim F. Greten, MD, senior investigator thoracic and gastrointestinal oncology branch, head, gastrointestinal malignancy section, National Cancer Institute discusses promising immunotherapy agents being investigated in hepatocellular carcinoma (HCC).